• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学战中的糜烂性毒剂和神经毒剂。应对变化世界的去污和治疗策略。

Vesicants and nerve agents in chemical warfare. Decontamination and treatment strategies for a changed world.

作者信息

Devereaux Asha, Amundson Dennis E, Parrish J S, Lazarus Angeline A

机构信息

Pulmonary/Critical Care Medicine Division, Department of Internal Medicine, National Naval Medical Center, 36800 Bob Wilson Dr, San Diego, CA 92134, USA.

出版信息

Postgrad Med. 2002 Oct;112(4):90-6; quiz 4. doi: 10.3810/pgm.2002.10.1334.

DOI:10.3810/pgm.2002.10.1334
PMID:12400151
Abstract

Vesicants and nerve agents have been used in chemical warfare for ages. They remain a threat in today's altered political climate because they are relatively simple to produce, transport, and deploy. Vesicants, such as mustard and lewisite, can affect the skin, eyes, respiratory system, and gastrointestinal system. They leave affected persons at risk for long-term effects. Nerve agents, such as tabun, sarin, soman, and VX, hyperstimulate the muscarinic and nicotinic receptors of the nervous system. Physicians need to familiarize themselves with the clinical findings of such exposures and the decontamination and treatment strategies necessary to minimize injuries and deaths.

摘要

糜烂性毒剂和神经毒剂在化学战中已被使用多年。在当今变化了的政治环境中,它们仍然构成威胁,因为它们相对易于生产、运输和部署。糜烂性毒剂,如芥子气和路易氏剂,可影响皮肤、眼睛、呼吸系统和胃肠道系统。它们使受害者面临长期影响的风险。神经毒剂,如塔崩、沙林、梭曼和VX,会过度刺激神经系统的毒蕈碱和烟碱受体。医生需要熟悉此类暴露的临床症状以及为尽量减少伤亡所需的去污和治疗策略。

相似文献

1
Vesicants and nerve agents in chemical warfare. Decontamination and treatment strategies for a changed world.化学战中的糜烂性毒剂和神经毒剂。应对变化世界的去污和治疗策略。
Postgrad Med. 2002 Oct;112(4):90-6; quiz 4. doi: 10.3810/pgm.2002.10.1334.
2
Chemical warfare. Toxicity of nerve agents.化学战。神经毒剂的毒性。
Crit Care Nurse. 2003 Oct;23(5):15-20; quiz 21-2.
3
Chemical terrorism: a primer for 2002.化学恐怖主义:2002年入门指南。
J Assoc Acad Minor Phys. 2002 Jan;13(1):14-8.
4
Inhalational exposure to nerve agents.吸入神经性毒剂。
Respir Care Clin N Am. 2004 Mar;10(1):59-74. doi: 10.1016/S1078-5337(03)00049-2.
5
A review of nerve agent exposure for the critical care physician.重症监护医生对神经毒剂暴露情况的综述。
Crit Care Med. 2002 Oct;30(10):2346-54. doi: 10.1097/00003246-200210000-00026.
6
Nerve agents: implications for anesthesia providers.神经毒剂:对麻醉医护人员的影响。
AANA J. 2008 Apr;76(2):95-7.
7
Mustard gas: imminent danger or eminent threat?芥子气:迫在眉睫的危险还是重大威胁?
Ann Pharmacother. 2008 Feb;42(2):237-46. doi: 10.1345/aph.1K445. Epub 2008 Jan 22.
8
Measurement of breakthrough volumes of volatile chemical warfare agents on a poly(2,6-diphenylphenylene oxide)-based adsorbent and application to thermal desorption-gas chromatography/mass spectrometric analysis.基于聚(2,6 - 二苯基苯醚)的吸附剂对挥发性化学战剂穿透体积的测定及其在热脱附 - 气相色谱/质谱分析中的应用。
J Chromatogr A. 2015 Sep 4;1410:19-27. doi: 10.1016/j.chroma.2015.07.077. Epub 2015 Jul 22.
9
[Today's threat of use of organophosphorus compounds].[当今有机磷化合物的使用威胁]
Pol Merkur Lekarski. 2015 Sep;39(231):176-80.
10
Limitations and challenges in treatment of acute chemical warfare agent poisoning.急性化学战剂中毒治疗的局限性和挑战。
Chem Biol Interact. 2013 Dec 5;206(3):435-43. doi: 10.1016/j.cbi.2013.09.015. Epub 2013 Sep 30.

引用本文的文献

1
Ophthalmic manifestations and management considerations for emerging chemical threats.新型化学威胁的眼部表现及管理考量
Front Toxicol. 2023 Oct 18;5:1281041. doi: 10.3389/ftox.2023.1281041. eCollection 2023.
2
Long-term Health Outcomes Among Survivors Exposed to Sulfur Mustard in Iran.伊朗芥子气暴露幸存者的长期健康结局。
JAMA Netw Open. 2020 Dec 1;3(12):e2028894. doi: 10.1001/jamanetworkopen.2020.28894.
3
Sulfur mustard gas exposure: case report and review of the literature.硫芥气暴露:病例报告及文献综述
Ann Burns Fire Disasters. 2014 Sep 30;27(3):146-50.
4
Chemical warfare agents.化学战剂
J Pharm Bioallied Sci. 2010 Jul;2(3):166-78. doi: 10.4103/0975-7406.68498.